Hydrogen Cyanide Generation by Pseudomonas aeruginosa Blunts the Host Innate Immune Response
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag244 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Csaba Szabo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Immunity, Innate, Hydrogen Cyanide, Pseudomonas Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The biological mediator hydrogen cyanide (HCN) is produced by certain pathogenic bacteria. Hydrogen cyanide exerts multiple effects in mammalian cells: at low concentrations, it has cytoprotective regulatory effects, whereas at high concentrations, it blocks mitochondrial electron transport by inhibiting cytochrome c oxidase, thereby halting cellular metabolism. Here, we evaluated whether bacterial HCN confers resistance to the host immune response. We used Pseudomonas aeruginosa as a model organism, since it is a clinically significant HCN-generating bacterial species and a common cause of nosocomial infections.
Methods
The study used bacterial mutants, macrophage co-cultures, cyanide quantification, phagocytosis and bioenergetics assays, and mouse infection models to assess HCN's role in immune evasion.
Results
Compared with wild-type P. aeruginosa, genetically HCN-deficient bacteria were more susceptible to killing by immune cells in vitro and were cleared more rapidly in mouse models of systemic infection. Increased leukocyte killing was not due to increased phagocytosis. Pharmacological scavenging of HCN also enhanced leukocyte bacterial killing.
Conclusions
These findings support the concept that HCN acts as a bacterial defense mechanism against the host's immune response. Targeting bacterial HCN could be a potential therapeutic strategy to improve the immune clearance of P. aeruginosa infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.
- Section of Microbiology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.
- Department of Medicine, University of California, San Diego, La Jolla, California, USA.
ORCID-Profile: Csaba Szabo, Jacqueline Findlay, Thilo Magnus Philipp, Patrice Nordmann
Zitieren
APA
Szabo, C., Santos, S. S., Findlay, J., Bremer, O., Petrosino, M., Philipp, T. M., Kierońska-Rudek, A., Zuhra, K., Boss, G. R., & Nordmann, P. (2026). Hydrogen Cyanide Generation by Pseudomonas aeruginosa Blunts the Host Innate Immune Response. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag244
Vancouver
Szabo C, Santos SS, Findlay J, Bremer O, Petrosino M, Philipp TM, et al. Hydrogen Cyanide Generation by Pseudomonas aeruginosa Blunts the Host Innate Immune Response. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag244
BibTeX
@article{Szabo2026,
author = {Szabo, Csaba and Santos, Sidnéia Sousa and Findlay, Jacqueline and Bremer, Olivier and Petrosino, Maria and Philipp, Thilo Magnus and Kierońska-Rudek, Anna and Zuhra, Karim and Boss, Gerry R and Nordmann, Patrice},
title = {Hydrogen Cyanide Generation by Pseudomonas aeruginosa Blunts the Host Innate Immune Response},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag244}
}
EUVIMED